Clinical Performance of Two HEMA-Free Universal Adhesive Systems
ConditionCervical Caries
Trial statusNot yet recruiting
Trial phaseNot applicable
Trial typeInterventional
Biological sexAll
Age18-55
SponsorCairo University
About this trial
This randomized controlled clinical trial aims to compare the 12-month clinical performance of two HEMA-free universal adhesive systems for restoring anterior cervical carious lesions. Participants will be randomly allocated (1:1) to receive restorations using either a two-bottle HEMA-free universal adhesive (G2-Bond Universal) or a one-bottle HEMA-free universal adhesive (BeautiBond Xtreme), both applied in self-etch mode. The primary outcome is restoration retention, while secondary outcomes include marginal adaptation, marginal discoloration, and postoperative sensitivity, evaluated at baseline (24 hours), 6 months, and 12 months using the modified USPHS criteria.
Eligibility criteria
Qualifiers
Patients with cervical carious lesions on the labial surfaces of anterior teeth.
Lesions classified as ICDAS 3 and 4.
Patients with good general health.
Patients able and willing to attend the follow-up visits at baseline, 6 months and 12 months.
Disqualifiers
Patients with severe or chronic periodontal disease.
Patients with poor oral hygiene or uncontrolled plaque accumulation.
Patients with bruxism or other parafunctional habits that may affect restoration survival.
Non-vital teeth.
Trial design
Treatments tested in this trial
- G2-Bond Universal
- BeautiBond Xtreme Universal Adhesive
Treatment groups
50 Participants
are divided into 2 treatment groupsLocations
Sponsors and collaborators
Source ClinicalTrials.gov